Rockwell Medical, Inc. RMTI
6.61 USD -0.15 (-2.22%)
Regular-session close
6.61 0.00 0.00%
After hours · Nov 17, 4:00 PM ET
6.52 Day range 7.02
4.89 52-week range 12.90
- YTD
- -20.36%
- 1 year
- -24.02%
News
seekingalpha.com Rockwell Medical, Inc. (RMTI) Q3 2026 Earnings Call Transcript Rockwell Medical, Inc. (RMTI) Q3 2026 Earnings Call Transcript
benzinga.com Rockwell Medical Q3 2026 Earnings Call Transcript Rockwell Medical (NASDAQ:RMTI) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
zacks.com Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates Rockwell Medical (RMTI) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.5 per share a year ago.
businesswire.com Rockwell Medical Announces Third Quarter 2026 Results WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q3'26 results, grew net sales 20% YoY reflecting strong customer adoption of our hemodialysis concentrates…
defenseworld.net Rockwell Medical to Buy Vantive Dialysis Business in $125M Deal, Targeting Global Growth Rockwell Medical (NASDAQ: RMTI) said it has entered an equity and asset purchase agreement with Vantive Limited to acquire Vantive's global hemodialysis concentrates, hemodialysis machines, water…
seekingalpha.com Rockwell Medical, Inc. (RMTI) M&A Call Transcript Rockwell Medical, Inc. (RMTI) M&A Call Transcriptbenzinga.com Rockwell Medical To Acquire Majority Of Vantive's Hemodialysis Business; Terms Not Disclosed Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today announced that it has entered into a definitive agreement with Rockwell Medical, Inc. (NASDAQ:RMTI) to…
prnewswire.com Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical Sharpens Vantive's Focus on Home Dialysis and Critical Care DEERFIELD, Ill., Nov. 3, 2026 /PRNewswire/ -- Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today…
businesswire.com Rockwell Medical Announces Transformational Global Hemodialysis Acquisition WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical is acquiring Vantive's HD concentrates, HD machines, water treatment systems, and related consumables and technical…
businesswire.com Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026 WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026.
businesswire.com Rockwell Medical to Exhibit at ASN Kidney Week 2026 WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Come visit Rockwell Medical in Booth #1049 at ASN Kidney Week 2026 at the Colorado Convention Center in Denver, CO.
businesswire.com Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' List WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--This marks the 3rd consecutive year that Rockwell Medical earned this recognition—climbing the ranks from #50 (2024) and #40 (2025) to…
defenseworld.net Reviewing Rockwell Medical (NASDAQ:RMTI) & Embecta (NASDAQ:EMBC) Embecta (NASDAQ: EMBC - Get Free Report) and Rockwell Medical (NASDAQ: RMTI - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two…
seekingalpha.com Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
zacks.com Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates Rockwell Medical (RMTI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.5 per share a year ago.
gurufocus.com Rockwell Medical Announces Second Quarter 2026 Results Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodial
businesswire.com Rockwell Medical Announces Second Quarter 2026 Results WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q2'26 results, delivering strong year-over-year growth, expanding gross margin and generating positive…
zacks.com Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
businesswire.com Rockwell Medical Advances Quality and Regulatory Leadership WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Brian Cox joins Rockwell Medical as VP, Quality and Regulatory Compliance, bringing more than 20 years' healthcare experience to the…
businesswire.com Rockwell Medical Regains Compliance with Nasdaq Listing Requirements WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical received notice from Nasdaq that it regained compliance with the minimum bid price requirement under Nasdaq Listing…
businesswire.com Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026 WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026.
businesswire.com Rockwell Medical Announces 1-for-10 Reverse Stock Split WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's Board of Directors has authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock.
